Enalapril maleate (Aqumeldi®). HTA ID: 24011

Assessment Status Rapid Review complete
HTA ID 24011
Drug Enalapril maleate
Brand Aqumeldi®
Indication For the treatment of heart failure in children and adolescents from birth to less than 18 years of age.
Assessment Process
Rapid review commissioned 25/03/2024
Rapid review completed 12/04/2024
Rapid review outcome A full HTA is not recommended. The NCPE recommends that enalapril maleate mini ODTs not be considered for reimbursement at the submitted price.*

*This recommendation should be considered while also having regard to the criteria specified in the Health (Pricing and Supply of Medical Goods) Act 2013.